Vertex Pharmaceuticals (NASDAQ:VRTX) shares rose 6% to $488.52 in premarket trading Thursday after the company reported successful results from a late-stage trial ...

Why Vertex Stock Is Drawing Attention Now Vertex (VERX) has been getting a closer look from investors after its recent share performance, with the stock showing mixed returns over the past week, month ...

Vertex Pharmaceuticals VRTX announced positive data from an interim analysis of the ongoing phase III RAINER study, which evaluated its investigational drug povetacicept for IgA nephropathy (IgAN), a ...

Vertex delivers tax technology software and SaaS solutions to corporations seeking streamlined compliance and integration capabilities.

Check out some of the companies making the biggest moves midday: Hims & Hers Health — Shares of the telehealth company jumped ...

Vertex Pharmaceuticals (VRTX) stock climbed 5% after povetacicept showed strong phase 3 results in IgA nephropathy, with FDA filing planned by March.

The stock looks like a great pick to help turn investors into multimillionaires, given enough time. Everyone should save ...

The drug maker says its treatment of a rare kidney disease met its main goal in a late-stage trial.

What Happened? Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 8.3% in the afternoon session after the company announced positive results from a late-stage trial for its ...

Kohl's — Shares tumbled 9% after the retailer posted disappointing fourth-quarter revenue of $4.97 billion, below the LSEG consensus of $5.03 billion. On the other hand, fourth quarter earnings of $1.

Gene editing, a set of techniques used to alter sections of an organism's DNA, is helping scientists cure diseases previously ...

↘️ Boeing (BA): The plane maker will delay some 737 MAX deliveries after discovering a problem with wiring. The stock was down 3.2%. ↗️ Micron Technology (MU), Applied Materials (AMAT): The companies ...